Theseus Pharma Lays Off Staff, Explores Options Months After Toxicity Scuttles Lead Drug

siteadmin November 14, 2023

Theseus Pharmaceuticals is laying off 72% of its staff and exploring potential deals after its lead cancer drug revealed dose-limiting toxicities. The firm anticipates $5.5m in severance costs to be incurred this quarter. Despite the layoffs, Theseus still plans to further develop its pipeline, which could include treatments for lung cancer and other forms of gastrointestinal cancer.